Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Michael Okunewitch — Maxim Group — Analyst _________ To read the […]
“Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Michael Okunewitch — Maxim Group — Analyst _________ To read the […]
· April 1, 2021
Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021.
Jody Cain — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Michael Okunewitch — Maxim Group — Analyst
_________
To read the full earnings call transcript, click here
